Top picks in English

Odense-based company sells product for research - halves the need for external capital before FDA approval

Implant company Particle 3D is selling its 3d-printed bone material for research use while the company works towards FDA approval. This has reduced the need to raise external capital from DKK 100 million (USD 14.7 million) to DKK 40-50 million (USD 5.9-7.4 million).
Particle 3D will now sell its 3D printed bone material to researchers, before it is approved as implants in humans. | Foto: Particle 3D/PR
Particle 3D will now sell its 3D printed bone material to researchers, before it is approved as implants in humans. | Foto: Particle 3D/PR
af ULRICH QUISTGAARD

When a researcher at a Danish university asked the people behind Particle3D whether they could help him out with some 3D printed material that resembled bone, it was a much more important question for the company that it first appeared.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
    • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Relaterede artikler

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også

    Job